Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma.
CONCLUSIONS: Concurrent CRT is a well-tolerated treatment option with no additional toxicity compared to exclusive radiotherapy or sequential CRT.
PMID: 29714662 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Radiation Therapy | Sarcomas | Skin | Soft Tissue Sarcoma | Study | Toxicology